Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?
Alaklabi, Sabah, Roy, Arya Mariam, Chaudhary, Lubna N, Gandhi, Shipra
Published in Exploration of targeted anti-tumor therapy (2023)
Published in Exploration of targeted anti-tumor therapy (2023)
Get full text
Journal Article
Evaluating the Accuracy, Quality, and Readability of Online Breast Cancer Information
Valencia, Elsie A, Cortina, Chandler S, Cobb, Adrienne N, Chaudhary, Lubna N, Kelly, Tracy, Kong, Amanda L
Published in Annals of surgery open (01.09.2024)
Published in Annals of surgery open (01.09.2024)
Get full text
Journal Article
Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?
Chaudhary, Lubna N, Wilkinson, K Hope, Kong, Amanda
Published in Surgical oncology clinics of North America (01.01.2018)
Published in Surgical oncology clinics of North America (01.01.2018)
Get more information
Journal Article
National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial
Rogers, Christine, Cobb, Adrienne N., Lloren, Jan I. C., Chaudhary, Lubna N., Johnson, Morgan K., Huang, Chiang-Ching, Teshome, Mediget, Kong, Amanda L., Singh, Puneet, Cortina, Chandler S.
Published in Breast cancer research and treatment (2024)
Published in Breast cancer research and treatment (2024)
Get full text
Journal Article
Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer
Kamaraju, Sailaja, Fowler, Amy M, Weil, Elizabeth, Wisinski, Kari B, Truong, Thu H, Lehr, Martin, Chaudhary, Lubna N, Cheng, Yee Chung, Chitambar, Christopher R, Rui, Hallgeir, Yee, Douglas, Lange, Carol
Published in Endocrinology (Philadelphia) (01.08.2021)
Published in Endocrinology (Philadelphia) (01.08.2021)
Get full text
Journal Article
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy
Chaudhary, Lubna N., Jorns, Julie M., Sun, Yunguang, Cheng, Yee Chung, Kamaraju, Sailaja, Burfeind, John, Gonyo, Mary Beth, Kong, Amanda L., Patten, Caitlin, Yen, Tina, Cortina, Chandler S., Carson, Ebony, Johnson, Nedra, Bergom, Carmen, Tsaih, Shirng-Wern, Banerjee, Anjishnu, Wang, Yu, Chervoneva, Inna, Weil, Elizabeth, Chitambar, Christopher R., Rui, Hallgeir
Published in Breast cancer research and treatment (01.10.2023)
Published in Breast cancer research and treatment (01.10.2023)
Get full text
Journal Article
Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience
Krishnan, Jayasree, Patel, Archit, Roy, Arya Mariam, Alharbi, Malak, Kapoor, Ankita, Yao, Song, Khoury, Thaer, Hong, Chi-Chen, Held, Nicole, Chakraborty, Anumita, Kaliniski, Pawel, Salman, Ahmed, Catalfamo, Kayla, Attwood, Kristopher, Kirtani, Vatsala, Shaikh, Saba S., Chaudhary, Lubna N., Gandhi, Shipra
Published in Clinical breast cancer (06.08.2024)
Published in Clinical breast cancer (06.08.2024)
Get full text
Journal Article
Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection
Pierro, Michael, Zurko, Joanna, Szabo, Anika, Cheng, Yee Chung, Kamaraju, Sailaja, Burfeind, John, Retseck, Janet, Chitambar, Christopher R, Chaudhary, Lubna N
Published in Wisconsin medical journal (Madison, Wis.) (01.12.2023)
Get full text
Published in Wisconsin medical journal (Madison, Wis.) (01.12.2023)
Journal Article
Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Alaklabi, Sabah, Roy, Arya Mariam, Zagami, Paola, Chakraborty, Anumita, Held, Nicole, Elijah, Joseph, George, Anthony, Attwood, Kristopher, Shaikh, Saba S, Chaudhary, Lubna N, Abdou, Yara, Gandhi, Shipra
Published in JCO oncology practice (01.10.2024)
Published in JCO oncology practice (01.10.2024)
Get more information
Journal Article
Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study
Sridhar, Nithya, Glisch, Chad, Jawa, Zeeshan, Chaudhary, Lubna N., Kamaraju, Sailaja, Burfeind, John, Charlson, John, Chitambar, Christopher R., Jorns, Julie M., Cheng, Yee Chung
Published in Journal of Cancer (2022)
Published in Journal of Cancer (2022)
Get full text
Journal Article
Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer
Jorns, Julie M, Sun, Yunguang, Kamaraju, Sailaja, Cheng, Yee Chung, Kong, Amanda, Yen, Tina, Patten, Caitlin R, Cortina, Chandler S, Chitambar, Christopher R, Rui, Hallgeir, Chaudhary, Lubna N
Published in Journal of personalized medicine (01.05.2024)
Published in Journal of personalized medicine (01.05.2024)
Get full text
Journal Article
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
Chervoneva, Inna, Peck, Amy R, Sun, Yunguang, Yi, Misung, Udhane, Sameer S, Langenheim, John F, Girondo, Melanie A, Jorns, Julie M, Chaudhary, Lubna N, Kamaraju, Sailaja, Bergom, Carmen, Flister, Michael J, Hooke, Jeffrey A, Kovatich, Albert J, Shriver, Craig D, Hu, Hai, Palazzo, Juan P, Bibbo, Marluce, Hyslop, Terry, Nevalainen, Marja T, Pestell, Richard G, Fuchs, Serge Y, Mitchell, Edith P, Rui, Hallgeir
Published in JCO precision oncology (01.01.2023)
Published in JCO precision oncology (01.01.2023)
Get more information
Journal Article
754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)
Spigel, David R, Hamilton, Erika, Bashir, Babar, Gergis, Usama, Murthy, Hemant S, Chumsri, Saranya, Migdady, Yazan, Specht, Jennifer, Chaudhary, Lubna N, Garber, Haven, Kim, Chul, Mamdani, Hirva, Fitzsimmons, Sarah, Ganguly, Bishwa J, Hiraragi, Hajime, Jensen, Helle, Kim, Yeonhee, Lessig, Mary C, Gillenwater, Heidi
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ?
Chaudhary, Lubna N, Jawa, Zeeshan, Hanif, Ahmad, Szabo, Aniko, Kamaraju, Sailaja, Cheng, Yee C, Chitambar, Christopher R
Published in Wisconsin medical journal (Madison, Wis.) (01.06.2018)
Get full text
Published in Wisconsin medical journal (Madison, Wis.) (01.06.2018)
Journal Article